Circio publishes wide-ranging review on potential of circular RNA therapeutics in Nature Reviews Genetics
· Circio scientists were invited to co-author a review article on the therapeutic potential of synthetic circular RNA and vector-based circular RNA expression · The article describes properties, technologies, applications, opportunities and challenges for circular RNA-based therapeutics · The review was published on 9 January 2025 in the prestigious high-impact journal Nature Reviews Genetics, which has an impact-factor of 39.1Oslo, Norway 13 January 2025 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing powerful circular RNA technology for next generation nucleic